Alkermes (ALKS) Gross Margin (2010 - 2026)

Alkermes' (ALKS) quarterly Gross Margin came in at 84.33% in Q1 2026, up 38.0% year-on-year from 61.11% in Q1 2025, and down 4.16% on a QoQ basis from 87.98% in Q4 2025.

Alkermes (ALKS) Gross Margin (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Gross Margin data on file, last reported at 84.33% in Q1 2026.

  • On a quarterly basis, Gross Margin rose 38.0% year-over-year to 84.33% in Q1 2026; TTM through Mar 2026 was 86.63%, a 222.0% increase from a year earlier, with the FY2025 full-year figure at 86.69%, up 244.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 84.33%, down from 87.98% in the prior quarter.
  • Over the last five years, Gross Margin for ALKS reached as high as 89.76% in Q2 2023 and fell as low as 1723.75% in Q2 2022.
  • Historically, Gross Margin has averaged 114.19% across 5 years, with a median of 83.86% in 2023.
  • Across the five-year window, Gross Margin slumped 180626 bps in 2022 and soared 181351 bps in 2023, its largest moves.
  • Year by year, Gross Margin stood at 82.3% in 2022, then retreated by 1 bps to 81.42% in 2023, then advanced by 5 bps to 85.55% in 2024, then advanced by 3 bps to 87.98% in 2025, then fell by 4 bps to 84.33% in 2026.
  • Per Business Quant data, the three most recent Gross Margin figures were 84.33% in Q1 2026, 87.98% in Q4 2025, and 86.91% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 49.52%
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 82.93%
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 57.26%
10 Alkermes 8.78 Bn 8.27 Bn 331.33 Mn 84.33%

Historic Data

Download Data
DateValue
Mar 31, 2026 84.33%
Dec 31, 2025 87.98%
Sep 30, 2025 86.91%
Jun 30, 2025 87.34%
Mar 31, 2025 83.95%
Dec 31, 2024 85.55%
Sep 30, 2024 83.31%
Jun 30, 2024 84.60%
Mar 31, 2024 83.26%
Dec 31, 2023 81.42%
Sep 30, 2023 83.86%
Jun 30, 2023 89.76%
Mar 31, 2023 79.78%
Dec 31, 2022 82.30%
Sep 30, 2022 -1,482.03%
Jun 30, 2022 -1,723.75%
Mar 31, 2022 80.20%
Dec 31, 2021 83.47%
Sep 30, 2021 83.15%
Jun 30, 2021 82.51%